Orexo AB (Orexo) today informs about the progress towards becoming a full
-fledged specialty pharmaceutical company with a US commercial presence. Orexo
also announced the company project it will turn profitable in late 2013, with
the current assumptions on regulatory timing and launch of Zubsolv™ in September
2013.
